Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1b/2a Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy
Sponsored by Longboard Pharmaceuticals, Inc.
Active
$543.6K Funding
2 People
External
Related Topics
clinical trials,
pharmacology,
safety,
efficacy,
dose escalation
People
David Labiner
Principal Investigator (PI)
Neurology
﹒Department Head
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
